S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
Main Authors: | Charles Dussiau, Thibault Comont, Camille Knosp, Ines Vergnolle, Clotilde Bravetti, Alban Canali, Amandine Houvert, Laetitia Largeaud, Christian Daveaux, Laila Zaroili, Chloe Friedrich, Ismael Boussaid, Loria Zalmai, Carole Almire, Odile Beyne-Rauzy, Lise Willems, Didier Bouscary, Olivier Gandrillon, Michaela Fontenay, Oliver Kosmider, Francois Vergez, Nicolas Chapuis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967560.87989.c2 |
Similar Items
-
Immune checkpoint inhibitor-related acral vasculitis
by: Thibault Comont, et al.
Published: (2018-11-01) -
Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patients
by: Estelle Balducci, et al.
Published: (2022-09-01) -
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
by: Olivier Kosmider, et al.
Published: (2016-07-01) -
From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
by: Thibault Comont, et al.
Published: (2021-10-01) -
Diagnosis of enteropathy‐associated T‐cell lymphoma (EATL) on peripheral blood: A pleiomorphic morphology and an unusual immunophenotype
by: Léa Ousset, et al.
Published: (2023-08-01)